In patients on chronic dialysis, unfractionated heparin (UFH) is the most commonly used
agent for anticoagulation of the hemodialysis extracorporeal circuit, for hemodialysis …

For decades, the use of unfractionated heparin (UFH) has been the basic principle of
anticoagulation in patients at risk of or with established thromboembolic disorders …

Low molecular weight heparins (LWMH) are the preferred initial treatment for many
thromboembolic disorders but are renally excreted and relatively contraindicated in patients …

The coagulation cascade is complex but well studied. Dialysis membranes and lines are
inherently pro‐coagulant and activate both the intrinsic and extrinsic pathways of …

Unfractionated heparin (UFH) is the anticoagulant of choice for most maintenance
hemodialysis units in the United States. Low molecular weight heparin (LMWH) is the norm …

Anticoagulation is essential to hemodialysis, and unfractionated heparin (UFH) is the most
commonly used anticoagulant in the United States. However, there is no universally …

Unfractionated heparin (UFH) is the most commonly used anticoagulant for hemodialysis
worldwide. However, UFH comprises a series of different molecules with variable biological …

Systemic anticoagulation in maintenance hemodialysis (HD) has historically been
considered necessary to maintain the extracorporeal circuit (ECC) and preserve dialysis …

Unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) are commonly
used to prevent clotting of the hemodialysis extracorporeal circuit and optimize hemodialysis …

Unfractionated heparin (UFH) is a series of molecules, and as such has variable
pharmacodynamics. Low‐molecular‐weight heparins were developed to improve both drug …